Eastman Chemical Company $EMN Shares Purchased by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership boosted its stake in Eastman Chemical Company (NYSE:EMNFree Report) by 101.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,425,806 shares of the basic materials company’s stock after purchasing an additional 718,502 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Eastman Chemical were worth $91,009,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the business. Lido Advisors LLC grew its stake in shares of Eastman Chemical by 0.6% in the fourth quarter. Lido Advisors LLC now owns 20,313 shares of the basic materials company’s stock worth $1,297,000 after acquiring an additional 125 shares in the last quarter. Generali Asset Management SPA SGR lifted its position in shares of Eastman Chemical by 9.6% during the 4th quarter. Generali Asset Management SPA SGR now owns 1,700 shares of the basic materials company’s stock worth $109,000 after purchasing an additional 149 shares during the last quarter. UMB Bank n.a. lifted its position in shares of Eastman Chemical by 6.2% during the 4th quarter. UMB Bank n.a. now owns 2,571 shares of the basic materials company’s stock worth $164,000 after purchasing an additional 150 shares during the last quarter. Jacobi Capital Management LLC lifted its position in shares of Eastman Chemical by 3.2% during the 4th quarter. Jacobi Capital Management LLC now owns 4,982 shares of the basic materials company’s stock worth $318,000 after purchasing an additional 153 shares during the last quarter. Finally, QRG Capital Management Inc. lifted its position in shares of Eastman Chemical by 0.7% during the 4th quarter. QRG Capital Management Inc. now owns 23,069 shares of the basic materials company’s stock worth $1,472,000 after purchasing an additional 158 shares during the last quarter. Institutional investors and hedge funds own 83.65% of the company’s stock.

Eastman Chemical Trading Up 0.1%

NYSE EMN opened at $75.27 on Tuesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.71 and a current ratio of 1.47. The firm has a market cap of $8.61 billion, a PE ratio of 21.82, a P/E/G ratio of 0.96 and a beta of 1.04. Eastman Chemical Company has a one year low of $56.11 and a one year high of $83.47. The firm’s fifty day moving average is $73.48 and its two-hundred day moving average is $70.91.

Eastman Chemical (NYSE:EMNGet Free Report) last posted its quarterly earnings data on Thursday, April 30th. The basic materials company reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.02. The company had revenue of $2.18 billion for the quarter, compared to analyst estimates of $2.17 billion. Eastman Chemical had a net margin of 4.62% and a return on equity of 8.88%. Eastman Chemical’s quarterly revenue was down 4.9% on a year-over-year basis. During the same period in the previous year, the business posted $1.91 earnings per share. Eastman Chemical has set its Q2 2026 guidance at 1.700-1.900 EPS. Analysts expect that Eastman Chemical Company will post 6.36 earnings per share for the current year.

Eastman Chemical Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 8th. Stockholders of record on Monday, June 15th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 4.5%. The ex-dividend date is Monday, June 15th. Eastman Chemical’s payout ratio is 97.39%.

Wall Street Analyst Weigh In

EMN has been the subject of several recent analyst reports. Wells Fargo & Company lifted their price objective on shares of Eastman Chemical from $70.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Monday, May 4th. Royal Bank Of Canada lifted their price objective on shares of Eastman Chemical from $79.00 to $82.00 and gave the stock a “sector perform” rating in a research report on Tuesday, May 5th. JPMorgan Chase & Co. lifted their price objective on shares of Eastman Chemical from $80.00 to $82.00 and gave the stock an “overweight” rating in a research report on Monday, May 4th. Morgan Stanley lifted their price objective on shares of Eastman Chemical from $73.00 to $83.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 5th. Finally, Citigroup lifted their price objective on shares of Eastman Chemical from $83.00 to $88.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Seven research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.25.

Get Our Latest Stock Report on Eastman Chemical

Eastman Chemical Profile

(Free Report)

Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.

The company’s main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.

Read More

Want to see what other hedge funds are holding EMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eastman Chemical Company (NYSE:EMNFree Report).

Institutional Ownership by Quarter for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.